跳至主要内容
临床试验/IRCT2015050912571N2
IRCT2015050912571N2已完成2 期

The effects of a newly designed natural sweetener (Lacritose) compared to sucrose and glucose on blood glucose concentrations and possible gastrointestinal reactions in patients with type 2 diabetes: a double-blind randomized three way cross-over clinical trial

Vice chancellor for research, Shahid Sadoughi University of Mecical Sciences0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 60 years(—)
性别
All

入选标准

  • Type 2 diabetic patients (n=20) with fasting blood sugar >125 mg/dl and lower than 200 mg/dl, aged 20 to 60.
  • Exclusion criteria:
  • Participants will not be included in the trial if they were pregnant or lactating, had severe infection, endocrine disorders or acute diseases at the enrollment. Participants who intend to exit with any reasons or show any adverse reaction to test sugars will also be excluded from the study. .

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Shahid Sadoughi University of Mecical Sciences

相似试验

The safety and effect of a new sweetener (Lacritose)... | 临床试验